Explore
Validate
LearnHPA040304
antibody from Atlas Antibodies
Targeting: YBX1
BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA040304 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA040304, RRID:AB_10795364
- Product name
- Anti-YBX1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human YBX1, Gene description: Y box binding protein 1, Alternative Gene Names: BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1, Validated applications: ICC, IHC, WB, Uniprot ID: P67809, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer
El Hage K, Babault N, Maciejak O, Desforges B, Craveur P, Steiner E, Rengifo-Gonzalez J, Henrie H, Clement M, Joshi V, Bouhss A, Wang L, Bauvais C, Pastré D
eLife 2023;12
eLife 2023;12
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer
Lefort S, El-Naggar A, Tan S, Colborne S, Negri G, Pellacani D, Hirst M, Gusterson B, Morin G, Sorensen P, Eaves C
Cell Death & Differentiation 2021;29(1):54-64
Cell Death & Differentiation 2021;29(1):54-64
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Western blot analysis in HEK293 cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-YBX1 antibody. Remaining relative intensity is presented. Loading control: Anti-PPIB.
- Sample type
- Human
- Protocol
- Protocol
